Abstract
Rationale Mechanical ventilation plays an important role in critical illness-associated diaphragm weakness. Weakness contributes to difficult weaning and is associated with increased morbidity and mortality. Diaphragm weakness is caused by a combination of atrophy and dysfunction of myofibers, which are large syncytial cells maintained by a population of myonuclei. Each myonucleus provides gene transcripts to a finite fiber volume, termed the myonuclear domain. Changes in myonuclear number in myofibers undergoing atrophy has not been investigated in mechanically ventilated ICU patients. Myonuclear number is a determinant of transcriptional capacity, and therefore critical for muscle regeneration after atrophy.
Objectives Our objective was to investigate if and how myonuclear number changes in the diaphragm of mechanically ventilated ICU patients and whether changes are associated with myofiber atrophy.
Methods We used a combination of transcriptomics, immunohistochemistry, and confocal microscopy to study myonuclear alterations in diaphragm and quadriceps biopsies from mechanically ventilated ICU patients.
Results Myonuclear number and myonuclear domain were reduced in patients with diaphragm myofiber atrophy. Intrinsic apoptotic pathway activation was identified as a mechanism underlying myonuclear removal in the diaphragm of mechanically ventilated ICU patients. Total transcriptional activity in myofibers decreased with myonuclear loss.
Furthermore, muscle stem cell number was reduced in the patients with diaphragm atrophy.
Conclusion We identified myonuclear loss due to intrinsic apoptotic pathway activation as a potential mechanism underlying diaphragm atrophy in mechanically ventilated patients. This provides novel insights in diaphragm weakness of ICU patients. Targeted therapies may limit development of diaphragm weakness and improve weaning outcome.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Supported by NHLBI grant HL-121500 (C.A.C.O.); ZonMW Grant 09120011910004 (C.A.C.O; L.H.)
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The biopsy protocol was approved by the institutional review board at Amsterdam UMC (location VUmc), the Netherlands.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Author contributions: WJC, CACO and TJK designed the study. WJC, ZHS and MvB, were responsible for sample collection, WJC, ZHS, RRB, SB, LB, HH, ABa, GJS performed experiments in the laboratory. ABe, CD, LH were responsible for patient recruitment. WJC, LB, HH and ABa were responsible for data collection and management. WJC, LB, HH and ABa performed statistical analysis and created figures. WJC drafted the manuscript. CACO, TJK, LH, RAB, and WJC critically revised the manuscript. All authors read and approved the manuscript.
Funding: Supported by NHLBI grant HL-121500 (C.A.C.O.); ZonMW Grant
The order of the figures was revised, the ICU group was split in an atrophy and no atrophy group later in the manuscript.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
